← All organizations

Zavante Therapeutics

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 1, 2016

Acquired by Nabriva Therapeutics AG on Jul 25, 2018

Timeline

2010s

Jun 1, 2015
Zavante Therapeutics— Founded
Jul 25, 2018
Nabriva Therapeutics AG— Acquired By

Drugs by trial phase (3 distinct, 1 trials)

Phase 3 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (1)

NCT02753946Lead sponsorPhase 2/Phase 3Apr 1, 2016

Details

Founded: San Diego, CA, US Jun 1, 2015
Last known activity: Apr 1, 2016